Neurocutaneous Disorder Market

The neurocutaneous syndrome is a group of neurologic disorders of brain, spine, and the peripheral nervous system. These diseases are lifelong conditions that may induce a tumor growth inside the skin, organs, skeletal bones, brain, and spinal cord. These disorders are usually genetic and arise due to abnormal cell development at the embryo stage. The result is characterized by the development of tumors in various parts of the body. Even though some can be diagnosed at birth, most of them do not display symptoms until late.
Neurocutaneous Disorder Market contains market size and forecasts of Neurocutaneous Disorder in Global, including the following market information:
Global Neurocutaneous Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neurocutaneous Disorder market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tuberous Sclerosis (TS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neurocutaneous Disorder include Pfizer, Johnson & Johnson, Medtronic, Abbott, Novartis, Roche, Sanofi, Takeda and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neurocutaneous Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurocutaneous Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neurocutaneous Disorder Market Segment Percentages, by Type, 2021 (%)
Tuberous Sclerosis (TS)
Neurofibromatosis (NF)
Sturge-Weber Syndrome
Von Hippel-Lindau (VHL)
Ataxia-Telangiectasia (A-T)
Others
Global Neurocutaneous Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neurocutaneous Disorder Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Diagnostic Centers
Others
Global Neurocutaneous Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neurocutaneous Disorder Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurocutaneous Disorder revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neurocutaneous Disorder revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Medtronic
Abbott
Novartis
Roche
Sanofi
Takeda
Allergan
Syneron Medical
Aleva NeurOthersapeutics
Abbott Laboratories
Bausch Health